Ryo Kanata

Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer

Masashi Sawada, Akiyoshi Kasuga, Takafumi Mie et al. · BMC Cancer · 2020 · 74 citations · Full text

Medicine, Oncology, Pharmacology +14

Improvement of Treatment Outcomes for Metastatic Pancreatic Cancer: A Real-world Data Analysis

Takashi Sasaki, Ryo Kanata, I. Yamada et al. · In Vivo · 2018 · 38 citations · Full text

Medicine, Oncology, Pharmacology +14

Novel risk factors for recurrent biliary obstruction and pancreatitis after metallic stent placement in pancreatic cancer

Tsuyoshi Takeda, Takashi Sasaki, Takafumi Mie et al. · Endoscopy International Open · 2020 · 22 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +16

Comprehensive comparison of clinicopathological characteristics, treatment, and prognosis of borderline resectable pancreatic cancer according to tumor location

Tsuyoshi Takeda, Takashi Sasaki, Yosuke Inoue et al. · Pancreatology · 2020 · 13 citations

Medicine, Oncology, Surgery +17

Ki-67 Labeling Index Variability Between Surgically Resected Primary and Metastatic Hepatic Lesions of Gastroenteropancreatic Neuroendocrine Neoplasms

Takaaki Furukawa, Masato Ozaka, Manabu Takamatsu et al. · International Journal of Surgical Pathology · 2021 · 10 citations

Medicine, Oncology, Pathology +17